Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial

Faster, Cleaner, Better.

Lakeshore Biopharma CO (LSBCF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 03/31

(Values in U.S. thousands)

	09-2024	12-2023	09-2023	06-2023	03-2023
Assets
Current Assets
Cash & Cash Equivalents	16,059	31,431	36,200	43,149	N/A
Receivables	75,564	56,916	59,802	68,630	N/A
Inventories	28,336	25,225	29,642	25,239	N/A
Other current assets	531	1,706	2,948	1,376	0
TOTAL	$121,634	$116,708	$130,172	$139,248	$N/A

Non-Current Assets
PPE Net	63,848	79,123	78,230	78,451	N/A
Intangibles	9,725	10,299	10,396	10,564	0
Other Non-Current Assets	9,238	7,127	5,622	5,604	0
TOTAL	$82,811	$96,549	$94,248	$94,619	$N/A

Total Assets	$204,445	$213,257	$224,419	$233,867	$N/A

Liabilities
Current Liabilities
Short Term Debt	41,141	59,847	25,452	23,749	N/A
Accounts payable and accrued liabilities	6,690	10,948	11,836	10,223	0
Accrued Expenses	55,926	52,820	54,051	55,209	N/A
TOTAL	$104,186	$124,649	$92,359	$90,196	$N/A

Non-Current Liabilities
Long Term Debt	11,221	17,658	50,414	47,508	N/A
Deferred Revenues	228	314	320	318	N/A
Other Non-Current Liabilities	633	901	926	1,255	0
TOTAL	$14,271	$21,612	$54,468	$52,227	$N/A

Total Liabilities	$118,457	$146,261	$146,827	$142,423	$N/A

Shareholders' Equity
Shares Outstanding, K	N/A	N/A	N/A	N/A	9,306
Common Shares	4	2	2	2	N/A
Retained earnings	-326,358	-300,215	-285,323	-268,978	N/A
Other shareholders' equity	-9,001	-7,915	-7,138	-7,275	0
TOTAL	$85,988	$66,996	$77,592	$91,444	$N/A

Total Liabilities And Equity	$204,445	$213,257	$224,419	$233,867	$0